Aker BioMarine AS reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 82.9 million compared to USD 79 million a year ago. Net income was USD 9.9 million compared to USD 0.2 million a year ago. Basic earnings per share from continuing operations was USD 0.11. Diluted earnings per share from continuing operations was USD 0.11.
For the full year, sales was USD 335.3 million compared to USD 277.2 million a year ago. Net loss was USD 9 million compared to net income of USD 10 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to basic earnings per share from continuing operations of USD 0.11 a year ago. Diluted loss per share from continuing operations was USD 0.1 compared to diluted earnings per share from continuing operations of USD 0.11 a year ago.